"i was told by someone at the company that they used a business center to have a legal address in the USA."
A Francophone company apparently with operations in Canada and France, and what's politely called an "accomodation address" in the US (conveniently close to the NE biotech hub, Boston) yet quoted on the US Pink Sheets with 258.4 million shares outstanding.
Wonder why they want a PK quote, let alone a US quote at all?
Incidentally I know of one confirmed penny stock scam that has a Nobel Laureate on its Scientific Advisory Board,and another (not so coincidentally co-located with the former) that received a $1 million pork barrel grant "to accelerate" research from the Federal Government, courtesy of their local Congresswoman, Louise Slaughter.
Academic connections and seemingly legitimate research are common fig leaves for penny biotech scams to wear.
The big question about Spencer Pharmaceutical is why the endless stream of unverifiable PRs, why the Pink Sheet listing, why the huge outstanding float and why the address of convenience?
Answers on a postcard to the SEC, please.
Market Data 
Markets 
AI
